EF-Lumber Peripheral Drug-Eluting Stent

A drug-eluting stent system designed for peripheral vascular applications. It provides structural support while releasing therapeutic agents to reduce restenosis in peripheral arteries.

Drug-eluting stent for peripheral vascular interventions. Designed to expand narrowed peripheral vessels and maintain vessel patency.

A coronary stent coated with antiproliferative medication to reduce restenosis rates following percutaneous coronary intervention. Provides sustained drug delivery to the vessel wall over extended periods.

Advanced stent platform with pharmaceutical coating for coronary applications. Reduces restenosis risk while maintaining vessel patency in patients with coronary artery disease.

Bioresorbable drug-eluting stent system designed for peripheral vascular intervention in patients with stenotic or occluded peripheral arteries. The stent gradually resorbs while delivering therapeutic agents to prevent restenosis, restoring blood flow in lower extremity and other peripheral vascular applications.

A coronary stent system designed to deliver therapeutic agents directly to arterial lesions, reducing restenosis rates in percutaneous coronary intervention procedures. Manufactured in Vietnam with proven clinical efficacy and biocompatibility.

Drug-eluting coronary stent for percutaneous transluminal coronary angioplasty reducing restenosis in atherosclerotic lesions.

Interventional device for treating peripheral artery disease in lower extremities and other peripheral vessels. Restores blood flow in stenosed or occluded peripheral arteries.

A peripheral stent system eluting paclitaxel to treat stenotic lesions in lower extremity arteries. Provides mechanical support while delivering antiproliferative medication to prevent restenosis.

Advanced drug-eluting stent coatings that deliver pharmaceutical agents with controlled release profiles to prevent vessel restenosis. These specialty coatings combine hydrophilic polymers with active drug compounds, applied to stent surfaces to enhance biocompatibility and clinical efficacy in cardiovascular interventions.

Stent device coated with medication for coronary, peripheral, and cerebrovascular applications. Used to expand narrowed or blocked blood vessels while preventing restenosis.

Drug-eluting stent platforms that combine mechanical support with pharmaceutical delivery mechanisms for vascular applications. The product line includes multiple proprietary formulations and coating technologies.